Key result
Inpatient HbA1c testing is linked to ~34% higher post-AMI glucose therapy intensification.
Why the study?
The relationship between inpatient A1C assessment and glucose therapy intensification in patients with diabetes mellitus hospitalized for acute myocardial infarction was unclear.
Does routine clinical A1C assessment increase the likelihood of glucose therapy intensification at hospital discharge in patients with diabetes mellitus hospitalized for acute myocardial infarction?
Cohort (n=1,274)
Yes
Does routine clinical A1C assessment increase the likelihood of glucose therapy intensification at hospital discharge in patients with diabetes mellitus hospitalized for acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Inpatient clinical A1C assessment is independently associated with higher rates of discharge glucose-lowering therapy intensification in patients with diabetes hospitalized for acute myocardial infarction, particularly among those with suboptimal or poor glycemic control.
OBJECTIVE: To evaluate the relationship between A1C and glucose therapy intensification (GTI) in patients with diabetes mellitus (DM) hospitalized for acute myocardial infarction (AMI). RESEARCH DESIGN AND METHODS: A1C was measured as part of routine care (clinical A1C) or in the core laboratory (laboratory A1C, results unavailable to clinicians). GTI predictors were identified using hierarchical Poisson regression. RESULTS: Of 1,274 patients, 886 (70%) had clinical A1C and an additional 263 had laboratory A1C measured. Overall, A1C was <7% in 419 (37%), 7-9% in 415 (36%), and >9% in 315 patients (27%). GTI occurred in 31% of patients and was more frequent in those with clinical A1C both before (34 vs. 24%, P < 0.001) and after multivariable adjustment (relative risk 1.34 [95% CI 1.12-1.62] vs. no clinical A1C). CONCLUSIONS: Long-term glucose control is poor in most AMI patients with DM, but only a minority of patients undergo GTI at discharge. Inpatient A1C assessment is strongly associated with intensification of glucose-lowering therapy.
No takes yet. Share an insight, caveat, or question.
Stolker et al. (2012) conducted a cohort in Diabetes mellitus hospitalized for acute myocardial infarction (n=1,274). Clinical HbA1c assessment (measured during hospitalization or within the preceding 3 months) vs. No clinical HbA1c assessment (including those with core laboratory HbA1c only, unavailable to clinicians) was evaluated on Glucose therapy intensification (GTI) at hospital discharge (RR 1.34, 95% CI 1.12-1.62, p=<0.001). Clinical HbA1c assessment was associated with a 34% higher rate of glucose therapy intensification at discharge in patients with diabetes hospitalized for AMI.
Synapse has enriched 10 related papers. Consider them for comparative context: